午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

RD International Technology Co., Limited

RD International Technology Co., Limited

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 020-82000279
Mobile: 18024082417
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
SB-209670 C29H28O9 157659-79-5 Details
SR121566A C20H25N5O4S 180144-61-0 Details
BILB-1941 C34H34N4O4 494856-61-0 Details
GW-493838 C21H21ClFN7O4 253124-46-8 Details
PF-06795071 C18H17F4N3O3 2075629-81-9 Details
TFAX 488,TFP C33H29F4N3O11S2 878546-79-3 Details
MK-6240 Precursor C26 H27 N5 O6 1841444-11-8 Details
17-DMAP-GA C33H50N4O8 169521-68-0 Details
ERRγ Inverse Agonist 1 C30H37ClN2O2 2316832-86-5 Details
6-trans-12-epi-Leukotriene B4 C20H32O4 71548-19-1 Details
NCOA4 - 9a C27H28FN5 2650557-72-3 Details
1,1-Dibromo-3-chloroacetone C3H3Br2ClO 1578-18-3 Details
ML-9 Free Base C15H17ClN2O2S 110448-31-2 Details
Atorvastatin lactone D5 C33H33FN2O4 1217749-86-4 Details
SL910102 C30H30N6O 144756-71-8 Details
Adenosine 5'-succinate C14H17N5O7 102029-71-0 Details
Phthalimide-PEG3-C2-OTs C23H27NO8S 382162-12-1 Details
Daclatasvir Impurity C C29H32N6O3 1256385-55-3 Details
LY3020371 C15H15F2NO5S 1377615-75-2 Details
1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea C22H23N5O2S 1144075-40-0 Details
MK-447 C11H16INO 58456-91-0 Details
5,6-Dichlorovanillin C8H6Cl2O3 18268-69-4 Details
CGP-53153 C23H33N3O2 149281-19-6 Details
1,3-Dibromo-1,3-dichloroacetone C3H2Br2Cl2O 62874-84-4 Details
Thiamine diphosphate analog 1 C6H11NO7P2S 2606-90-8 Details
JMS-17-2 hydrochloride C25H27Cl2N3O 2341841-07-2 Details
(-)-SHIN1 C24H24N4O2 2444764-09-2 Details
Aβ42-IN-1 free base C29H26N4O2 2434633-17-5 Details
Mukanadin C C7H7BrN2O2 1839104-78-7 Details
UCB-J C17H15F3N2O 2242957-52-2 Details
Timobesone C22H29FO4S 87116-72-1 Details
DOTA derivative C43H50N4O8S4 153777-70-9 Details
Urinary Incontinence-Targeting Compound 1 C9H13FN2O3S 137315-05-0 Details
Rocagloic acid C27H26O8 190385-15-0 Details
Dox-Ph-PEG1-Cl C11H13ClO3 773095-86-6 Details
N-acetyl Dapsone (D4') C14H14N2O3S 2070015-28-8 Details
Kgp-IN-1 hydrochloride C19H25ClF4N4O3 2097865-47-7 Details
TV 3279 C16H20N2O2 209394-29-6 Details
Diarylalkane derivative 1 C34H51NO4 191155-65-4 Details
chaetoglobosin Vb C32H36N2O5 1399690-75-5 Details
Prinomide tromethamine C15H13N3O2.C4H11NO3 109636-76-2 Details
PD-1/PD-L1-IN 5 TFA C24H19F3N4O5S 2170209-52-4 Details
Hepatitis Virus C NS3 Protease Inhibitor 2 C43H56N6O14S 208939-95-1 Details
19-Heptatriacontanol C37H76O 872307-34-1 Details
Tebufelone C20H28O2 112018-00-5 Details
Orotidine 5′-monophosphate C10H13N2O11P 2149-82-8 Details
PI5P4Ks-IN-2 C22H23N5 2766854-03-7 Details
Maltoheptaose hydrate C42H74O37 331748-09-5 Details
O-Methylpodocarpic acid C18H24O3 10037-26-0 Details
LH secretion antagonist 1 C18H24ClNO2 88531-67-3 Details
7-Oxotridecanedioic acid C13H22O5 101171-43-1 Details
BI-1230 C42H52N6O9S 849022-32-8 Details
(R,1R)-Tenofovir amibufenamide C22H31N6O5P 1571076-37-3 Details
(S,R,S)-AHPC-Me-C10-NH2 hydrochloride C34H54ClN5O4S 2471970-07-5 Details
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)- C23H27N3O5 2247932-38-1 Details
3,4,5-Trichlorosyringol C8H7Cl3O3 2539-26-6 Details
Microcolin B C39H65N5O8 141205-32-5 Details
Chitohexaose hexahydrochloride C36H69ClN6O25 127171-88-4 Details
N-(Biotin-PEG4)-N-bis(PEG4-acid) C42H78N4O18S 2112731-48-1 Details
DBCO-C2-SulfoNHS ester C23H18N2O8S 1803279-86-8 Details
17-GMB-APA-GA C39H53N5O11 256337-10-7 Details
WCK-5153 1436862-38-2 Details
SW209049 C25H18N2O4S 1673558-59-2 Details
Seclazone C10H8ClNO3 29050-11-1 Details
(R)-Plevitrexed C26H25FN8O4 153537-74-7 Details
4-Aza-Oleanolic acid methyl ester C28H43NO3 557766-15-1 Details
Elacestrant S enantiomer dihydrochloride C30H39ClN2O2 2309762-30-7 Details
Ilmetropium iodide C20H30INO3 129109-88-2 Details
9,10-Dichlorostearic acid C18H34Cl2O2 5829-48-1 Details
CHMFL-KIT-033 C23H18FN5O2 2351801-41-5 Details
Aeruginosin 865 C41H64N6O14 1611990-01-2 Details
TRC-766 C25 H24 Cl F3 N2 O3 S 1810734-44-1 Details
T3-ATA (S-isomer) C19H16I3NO6S 2438721-48-1 Details
Eptifibatide acetate 1248559-53-6 Details
Bimosiamose disodium C46H52Na2O16 187269-60-9 Details
JTK-109 C37H33ClFN3O4 480462-62-2 Details
LY-402913 C28H24ClN3O6 334970-65-9 Details
HKOCl-4 C38H35Cl2NO7 2031170-85-9 Details
T4-ATA (S-isomer) C19H15I4NO6S 2448470-97-9 Details
A3334 C17H13N3O3 854171-31-6 Details
Soluplus 402932-23-4 Details
PYBG-BODIPY C38H39BF2N10O3 2068027-79-0 Details
RDR03871 C18H16ClF3N6 286008-51-3 Details
Usmarapride C23H31N5O6 1428862-33-2 Details
Lesopitron C15H21ClN6 132449-46-8 Details
Erythromycin ethylsuccinate- C23H25ClF2N4OS 2375781-06-7 Details
1-(2-fluoroethyl)-3-{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea C21H22FN5O2S 1144075-36-4 Details
1,2-diphenylpropan-2-amine C15H17N 118910-28-4 Details
Opaviraline C14H17FN2O3 178040-94-3 Details
FR167344 free base C30H28BrCl2N5O4 215258-13-2 Details
ML786 dihydrochloride C29H30ClF3N4O3 1237536-18-3 Details
Chitoheptaose heptahydrochloride C42H80ClN7O29 127171-89-5 Details
MK-8325 dihydrochloride C43H53ClF2N8O6Si 1334314-19-0 Details
Glycosidase-IN-1 C13H23NO5 170376-12-2 Details
RIP2 kinase inhibitor 1 C17H17N5O2S 2380028-10-2 Details
NH2-C2-amido-C2-Boc C10H20N2O3 1692613-62-9 Details
Neurodegenerative Disorder-Targeting Compound 1 C28H28N4O4 1254698-39-9 Details
Cys modifier 1 C18H15N5O5 2374314-08-4 Details
H-Asn-Arg-OH C10H20N6O4 2478-01-5 Details
NPEC-caged-LY379268 C16H16N2O9 1315379-62-4 Details
Product Total: Product Page:
74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99